title: Liver_cumulus_clone_4

description: Neonatal liver from cumulus clone mouse.

source_name: Neonatal liver from cumulus clone sample 4.

value: liver


title: Brain_Sertoli_clone_4

status: Public on Oct 04 2005

type: RNA

city: Tokyo

first: Takashi

last: Kohda

address: 1-5-45 Yushima, Bunko-ku

department: Medical Research Institute

country: Japan

institute: Tokyo Medical and Dental University

description: Neonatal brain from Sertoli clone mouse.

data_processing: Intensity is normalized to the mean raw intensity value

molecule: total RNA

organism: Mus musculus

source_name: Neonatal brain from Sertoli clone sample 4.

tag: Strain

value: C57BL/6 x DBA/2.

tag: Gender

value: male

tag: Age

value: neonate

tag: Tissue

value: brain


title: Brain_Sertoli_clone_3

source_name: Neonatal brain from Sertoli clone sample 3.


title: Brain_IVF_3

description: Neonatal brain from normal control produced by IVF.

source_name: Neonatal brain from normal control produced by IVF sample 3.


title: Brain_IVF_4

source_name: Neonatal brain from normal control produced by IVF sample 4.


title: Brain_Sertoli_clone_1

source_name: Neonatal brain from Sertoli clone sample 1.


title: Liver_cumulus_clone_2

source_name: Neonatal liver from cumulus clone sample 2.

value: female


title: Brain_cumulus_clone_3

description: Neonatal brain from cumulus clone mouse.

source_name: Neonatal brain from cumulus clone sample 3.


title: Localized Prostate Cancer Serum 13 (PCA-113)

type: protein

city: Ann Arbor

first: Xiaoju

last: Wang

state: MI

address: 1500 E. Medical Center Drive

country: USA

institute: University of Michigan

description: Serum sample from localized prostate cancer patient

molecule: protein

organism: Homo sapiens

source_name: Human serum IgG

source_name: T7 Phage Capsid Protein 10B


title: Localized Prostate Cancer Serum 12 (PCA-112)


title: Liver_cumulus_clone_3

source_name: Neonatal liver from cumulus clone sample 3.


title: Localized Prostate Cancer Serum 16 (PCA-116)


title: NF54-Tail-24h-3

city: Baltimore

first: Minoru

last: Ko

state: MD

address: 251 Bayview Blvd, Suite 100, 10C

department: National Institute on Aging

institute: NIH

hyb_protocol: Agilent 60-mer oligo microarray processing protocol (SSC Wash/SureHyb Chamber set-up) V4.1, April 2004.  Agilent Publication Number:  G4140-90030 V4.1 APRIL 2004.   The manual can be found at  https://www.chem.agilent.com/scripts/literaturePDF.asp?iWHID=34961,  or through a WEB search on the manual title.

data_processing: Data are extracted with Agilent Feature Extraction Software.The data were further processed with NIA ANOVA tool utilities.See http://lgsun.grc.nia.nih.gov/ANOVA for details.

organism: Xenopus laevis

label_protocol: Agilent Low RNA Input Fluorescent Linear Amplification Protocol

extract_protocol: standard method using TRIZOL reagent

treatment_protocol: Xenopus tadpole (NF54) were treated with 100 nM T3 for 24h in 0.1 X MMR solution.

tag: unknown sex NF Stage 54 (premetamorphic)

organism: unidentified

source_name: Universal RNA

extract_protocol: mRNAs were extracted with QuickPrep Micro mRNA Purification Kit from Amersham

tag: Universal RNA


title: Brain_Sertoli_clone_2

source_name: Neonatal brain from Sertoli clone sample 2.


title: Localized Prostate Cancer Serum 14 (PCA-114)


title: Localized Prostate Cancer Serum 9 (PCA-109)


title: Localized Prostate Cancer Serum 11 (PCA-111)


title: Localized Prostate Cancer Serum 15 (PCA-115)


title: Brain_IVF_2

source_name: Neonatal brain from normal control produced by IVF sample 2.


title: Brain_IVF_1

source_name: Neonatal brain from normal control produced by IVF sample 1.


title: Liver_Sertoli_clone_4

description: Neonatal liver from Sertoli clone mouse.

source_name: Neonatal liver from Sertoli clone sample 4.


title: Localized Prostate Cancer Serum 17 (PCA-117)


title: Localized Prostate Cancer Serum 18 (PCA-118)


title: Localized Prostate Cancer Serum 19 (PCA-119)


title: Liver_cumulus_clone_1

source_name: Neonatal liver from cumulus clone sample 1.


title: Localized Prostate Cancer Serum 6 (PCA-106)


title: Liver_IVF_4

description: Neonatal liver from normal control produced by IVF.

source_name: Neonatal liver from normal control produced by IVF sample 4.


title: Localized Prostate Cancer Serum 7 (PCA-107)


title: Localized Prostate Cancer Serum 8 (PCA-108)


title: Brain_cumulus_clone_1

source_name: Neonatal brain from cumulus clone sample 1.


title: Liver_Sertoli_clone_1

source_name: Neonatal liver from Sertoli clone sample 1.


title: Liver_Sertoli_clone_3

source_name: Neonatal liver from Sertoli clone sample 3.


title: Liver_Sertoli_clone_2

source_name: Neonatal liver from Sertoli clone sample 2.


title: Localized Prostate Cancer Serum 10 (PCA-110)


title: Liver_IVF_3

source_name: Neonatal liver from normal control produced by IVF sample 3.


title: Liver_IVF_1

source_name: Neonatal liver from normal control produced by IVF sample 1.


title: Liver_IVF_2

source_name: Neonatal liver from normal control produced by IVF sample 2.


title: Localized Prostate Cancer Serum 5 (PCA-105)

source_name: Human serum IgG


title: Localized Prostate Cancer Serum 4 (PCA-104)

source_name: T7 Phage Capsid Protein 10B


title: Localized Prostate Cancer Serum 2 (PCA-102)


title: Kidney_cumulus_clone_4

description: Neonatal kidney form cumulus clone.

source_name: Neonatal kidney from cumulus clone sample 4.

value: kidney


title: NF62-Tail-3

treatment_protocol: Xenopus tadpoles (NF61) were in 0.1 X MMR solution till they reached NF62 stage (about 48h).

tag: unknown sex NF Stage 62 (metamorphic climax)

source_name: Universal RNA


title: NF54-limb-24h-3

treatment_protocol: Xenopus tadpoles (NF54) were treated with 1 mM methimazole in 0.1 X MMR solution for 1 week to block the endogenous TH production and reduce the TH present in the system of the tadpole. They were then treated with 100 nM T3 in 1 mM methimazole and 0.1 x MMR for another 24h.

tag: N/A  unknown sex NF Stage 54 (premetamorphic)


title: Kidney_cumulus_clone_3

description: Neonatal kidney form cumulus clone.

source_name: Neonatal kidney from cumulus clone sample 3.


title: Kidney_cumulus_clone_2

description: Neonatal kidney from cumulus clone.

source_name: Neonatal kidney from cumulus clone sample 2.


title: Localized Prostate Cancer Serum 3 (PCA-103)


title: NF54-limb-14h-2

treatment_protocol: Xenopus tadpoles (NF54) were treated with 1 mM methimazole in 0.1 X MMR solution for 1 week to block the endogenous TH production and reduce the TH present in the system of the tadpole. They were then treated with 100 nM T3 in 1 mM methimazole and 0.1 x MMR for another 14h.


title: NF54-limb-14h-3


title: NF62-Tail-2


title: Kidney_cumulus_clone_1

description: Neonatal kidney from cumulus clone.

source_name: Neonatal kidney from cumulus clone sample 1.


title: Localized Prostate Cancer Serum 1 (PCA-101)


title: NF54-Tail-untreated-1

treatment_protocol: Xenopus tadpole (NF54) were in 0.1 X MMR solution for 48 hours


title: NF54-limb-24h-2


title: Kidney_Sertoli_clone_4

description: Neonatal kidney from Sertoli clone.

source_name: Neonatal kidney from Sertoli clone sample 4.


title: Animal pair 5 control

city: Phildelphia

first: Rishi

last: Khan

state: PA

address: 1020 Locust Street Room 381

department: Pathology

institute: Thomas Jefferson University

description: NTS punched from 250um slices and combined. RNA was isolated and amplified. Indirect labeling and hybridization at 37C overnight in a shaker at 50RPM.

source_name: Reference RNA

tag: PCR of vector of empty clone. Hybridizes to all spots evenly.

organism: Rattus norvegicus

source_name: Sample RNA

tag: 'Strain:Sprague-Dawley', 'Gender:Male', 'Tissue:Nucleus Tractus Solitarius'


title: NF54-limb-24h-1


title: Animal pair 4 control


title: Kidney_Sertoli_clone_3

description: Neonatal kidney from Sertoli clone.

source_name: Neonatal kidney from Sertoli clone sample 3.


title: Kidney_Sertoli_clone_2

description: Neonatal kidney from Sertoli clone.

source_name: Neonatal kidney from Sertoli clone sample 2.


title: Normal control serum 11 (Control-111)

description: Serum sample from normal control subject.


title: Normal control serum 9 (Control-109)


title: Normal control serum 10 (Control-110)


title: Animal pair 6 control


title: Animal pair 2 control


title: Kidney_Sertoli_clone_1

description: Neonatal kidney from Sertoli clone.

source_name: Neonatal kidney from Sertoli clone sample 1.


title: Animal pair 3 alcoholic


title: Animal pair 2 alcoholic


title: Time 240 mins rep 2

city: Dublin 8

first: Shane

middle: P

last: Duggan

state: dublin

address: James st hospital,

department: Clinical Medicine

country: Ireland

institute: Institute of Molecular Medicine

description: SKGT4 oesophageal cells stimulated low pH 6.5 for 240 minutes

source_name: Low pH stimulated SKGT4 cells


title: Normal control serum 8 (Control-108)


title: Kidney_IVF_4

description: Neonatal kidney from normal control produced by IVF.

source_name: Neonatal kidney from normal control produced by IVF sample 4.


title: Animal pair 4 alcoholic


title: Normal control serum 7 (Control-107)


title: Time 240 mins rep 1


title: Kidney_IVF_3

source_name: Neonatal kidney from normal control produced by IVF sample 3.


title: NF54-limb-48h-1

treatment_protocol: Xenopus tadpoles (NF54) were treated with 1 mM methimazole in 0.1 X MMR solution for 1 week to block the endogenous TH production and reduce the TH present in the system of the tadpole. They were then treated with 100 nM T3 in 1 mM methimazole and 0.1 x MMR for another 48h.


title: Time 180 mins rep 1

description: SKGT4 oesophageal cells stimulated low pH 6.5 for 180 minutes


title: Animal pair 1 control


title: Animal pair 1 alcoholic


title: Kidney_IVF_1

source_name: Neonatal kidney from normal control produced by IVF sample 1.


title: Normal control serum 3 (Control-103)

source_name: Human serum IgG


title: W2mef_clone4

city: Parkville

first: Ken

last: Simpson

state: Victoria

address: 1G Royal Parade

department: Genetics and Bioinformatics

country: Australia

institute: The Walter and Eliza Hall Institute

description: W2mef/c4/Nm parasite

data_processing: RMA (normexp background, quantile normalisation, median polish expression summaries)

label: W2mef clone4

organism: Plasmodium falciparum

source_name: RNA from late-stage trophozoites/early-stage schizonts


title: Normal control serum 4 (Control-104)

source_name: T7 Phage Capsid Protein 10B


title: EBA175null

description: W2mef parasite, EBA175 knockout

label: EBA175 null

tag: RNA from late-stage trophozoites/early-stage schizonts


title: Normal control serum 5 (Control-105)


title: Normal control serum 6 (Control-106)


title: Kidney_IVF_2

source_name: Neonatal kidney from normal control produced by IVF sample 2.


title: W2mef_Wt

description: wildtype W2mef parasite

label: W2mef wildtype


title: Normal control serum 1 (Control-101)


title: Normal control serum 2 (Control-102)


title: Time 30 mins rep 1

description: SKGT4 oesophageal cells stimulated with Low pH 6.5 for 30 minutes

source_name: Low pH Stimulated SKGT4 cells


title: Time 30 mins rep 2

description: SKGT4 oesophageal cells stimulated with low pH 6.5 for 30 minutes


title: Time 120 mins rep 2

description: SKGT4 oesophageal cells stimulated low pH 6.5 for 120 minutes


title: Time 120 mins rep 1


title: Time 0 mins rep 1

description: Resting non stimulated control cells.

source_name: SKGT4 cell line


title: Animal pair 6 alcoholic


title: CEA_SGF:AHC027#faible

status: Public on Oct 01 2005

city: EVRY

first: Michèle

middle: T

last: Martin

address: 2, rue Gaston Crémieux

department: DSV/DRR

country: France

institute: CEA

description: Human keratinocytes were isolated from mammary skin biopsies and the whole cell population was cultured for 2 passages under Green’s conditions. The Hoechst dye exclusion was completed on keratinocytes attached to the culture dish, in normal culture medium and conditions. SP and MP keratinocytes isolated from three independent cell sortings were pooled before RNA extraction. Total RNA was isolated directly after cell sorting from SP and MP keratinocytes using the RNA Microprep kit (Stratagene,#400805) following manufacturer’s protocol with the optional DNase treatment step. Extracted RNA was amplified using the MessageAmp RNA Kit (Ambion,#1750) following the instructions provided by the manufacturer. One amplification round was performed. Labelling of 1 ug of amplified RNA was performed by incorporation of aminoallyl-modified dUTP, followed by a subsequent incorporation of monofunctionnal Cy3 or Cy5-N-succinimide esters.

source_name: SP keratinocytes isolated from human primary cultured keratinocytes after cell amplification for 2 passages

source_name: MP keratinocytes isolated from human primary cultured keratinocytes after cell amplification for 2 passages


title: Time 0 mins rep 2

description: Resting non stimulated control cells.


title: lamivudine vs. mock in HepG2.2.15

city: Beijing

first: yong

last: guo

state: Beijing

address: Qinghuayuan

department: Medical Systems Biology Research Center

country: China

institute: Tsinghua University

description: the genomic influence of siRNA on HepG2.2.15

hyb_protocol: Labeled control and test samples were quantitatively adjusted based on the efficiency of Cy5-dCTP or Cy3-dCTP incorporation and mixed into 30 ¦Ìl hybridization solution (3¡ÁSSC, 0.2% SDS, 25% formamide and 5¡ÁDenhart¡¯s solution). DNA in hybridization solution was denatured at 95¡æ for 3 min before loading onto a microarray. The array was hybridized at 42¡æ overnight and washed with two consecutive washing solutions (0.2% SDS, 2¡ÁSSC at 42¡ãC for 5 min, and 0.2% SSC for 5 min at room temperature).

scan_protocol: Fluorescent array images were collected for both Cy3 and Cy5 with a ScanArray Express fluorescent scanner and image intensity data were extracted and analyzed with GenePix Pro 4.0 analysis software.

data_processing: A space and intensity-dependent normalization based on a LOWESS program was employed. For each test and control sample, two hybridizations were performed by using a reversal fluorescent strategy. Only genes whose alteration tendency kept consistency (both above 2-fold) in both microarray were selected as differentially expressed genes

source_name: HepG2.2.15,which express HBV

label_protocol: Fluorescent dye (Cy5 and Cy3-dCTP, Amersham Pharmacia Biotech, Piscataway, NJ) labeled DNA was produced through Eberwine's linear RNA amplification method.and subsequent enzymatic reaction. the amplified RNA (aRNA) was purified with RNeasy Mini Kit (Qiagen). Because sense oligonucleotide arrays were used here, we took a cDNA labeling approach with Klenow enzyme after reverse transcription.

extract_protocol: RNA isolation was accomplished with Qiagen RNeasy Mini Kit reagents

treatment_protocol: treated with 2um lamivudine

treatment_protocol: treated with mock


title: CEA_SGF:AHC034#faible


title: siRNA6 vs. pBSU6 in HepG2.2.15

hyb_protocol: Labeled control and test samples were quantitatively adjusted based on the efficiency of Cy5-dCTP or Cy3-dCTP incorporation and mixed into 30 ¦Ìl hybridization solution (3¡ÁSSC, 0.2% SDS, 25% formamide and 5¡ÁDenhart¡¯s solution). DNA in hybridization solution was denatured at 95¡æ for 3 min before loading onto a microarray. The array was hybridized at 42¡æ overnight and washed with two consecutive washing solutions (0.2% SDS, 2¡ÁSSC at 42¡ãC for 5 min, and 0.2% SSC for 5 min at room temperature)

label_protocol: Fluorescent dye (Cy5 and Cy3-dCTP, Amersham Pharmacia Biotech, Piscataway, NJ) labeled DNA was produced through Eberwine's linear RNA amplification method.and subsequent enzymatic reaction. the amplified RNA (aRNA) was purified with RNeasy Mini Kit (Qiagen). Because sense oligonucleotide arrays were used here, we took a cDNA labeling approach with Klenow enzyme after reverse transcription

treatment_protocol: transfection with anti-HBV siRNA7

treatment_protocol: transfection with negative contriol pBSU6


title: HepG2.2.15 vs. HepG2 replicate 2

description: the genomic influence of HBV on liver cell

source_name: HepG2.2.15,which express HBV  HepG2

treatment_protocol: No treat

treatment_protocol: no treat


title: lamivudine vs. mock in HepG2

description: the genomic influence of lamivudine on HepG2


title: HepG2.2.15 vs. HepG2


title: CEA_SGF:AHC031#faible


title: siRNA7 vs. pBSU6 in HepG2.2.15


title: CEA_SGF:AHC028#faible


title: CEA_SGF:AHC029#faible


title: siRNA1 vs. pBSU6 in HepG2

description: the genomic influence of siRNA on HepG2

treatment_protocol: transfection with anti-HBV siRNA1


title: siRNA7 vs. pBSU6 in HepG2

description: the genomic influence of siRNA on HepG2


title: Animal pair 5 alcoholic

source_name: Reference RNA

source_name: Sample RNA


title: HepG2.2.15 vs. HepG2 replicate 3


title: CEA_SGF:AHC030#faible


title: CEA_SGF:AHC033#faible


title: siRNA1 vs. pBSU6 in HepG2.2.15


title: pen3_Ec3

status: Public on Sep 30 2005

city: Stanford

first: Shauna

last: Somerville

state: CA

address: 260 Panama Street

department: Plant Biology

institute: Carnegie Institution of Washington

description: Three week-old mutant pen3 Arabidopsis thaliana plants, inoculated with Erisyphe cichoracearum.  Replicate 3 of four.

hyb_protocol: Hybridizations to ATH1 Arabidopsis GeneChips (Affymetrix) were done using the Affymetrix manufacturer’s protocols.

scan_protocol: standard Affymetrix procedures

data_processing: The array images were analyzed with the Affymetrix GeneChip Operating Software (GCOS) 1.1 with the target intensity set to 500. These data were imported into GeneSpring 7.0 (Silicon Genetics, Redwood City, CA, USA). To remove chip-to-chip signal variation, each measurement was divided by the 50.0th percentile of all measurements in that sample.  All samples were normalized to the reference data set, consisting of four replicates of Columbia-0, untreated. Each measurement for each gene was divided by the median of that gene’s intensity in the reference data set. The normalized values (Normalized Ratio) are reported along with the intensity values for this array.

label: biotin

organism: Arabidopsis thaliana

source_name: Whole Rossettes

label_protocol: Fifteen micrograms biotinylated complementary RNA (cRNA) was prepared.

growth_protocol: Plants were grown and inoculated as described (Nishimura et al., 2003, Science, 301, 969-972).

extract_protocol: Total RNA was extracted from the plants using a modified Trizol method (Chomczynski and Sashi, 1987) (see also Protocols Manual at the AFGC web page http://www.arabidopsis.org/info/2010_projects/comp_proj/AFGC/RevisedAFGC/AFGC_Protocols_Dec_2001L.pdf) and purified with a silica membrane column (Qiagen, RNeasy).

treatment_protocol: Growth Conditions and Treatments:  Three week-old wild-type Col and mutant pen3 Arabidopsis thaliana plants were inoculated with Erysiphe cichoracearum, Blumeria graminis hordei, or not inoculated.  1 day post inoculation 16 rosettes were harvested per replicate. 4 replicates were perfomerd per treatment.

tag: Genotype

value: Columbia-0, wild-type; Treatment:inoculated with Erisyphe cichoracearum; Biological Replicate:3 of four


title: Col_Bgh4

description: Three week-old wild-type Col  Arabidopsis thaliana plants, inoculated with Blumeria graminis hordei.  Replicate 4 of four.

value: Columbia-0, wild-type; Treatment:inoculated with Blumeria graminis hordei; Biological Replicate:4 of four


title: CEA_SGF:AHC032#faible


title: Animal pair 3 control


title: pen3_Un4

description: Three week-old mutant pen3 Arabidopsis thaliana plants, not inoculated.  Replicate 4 of four.

value: Columbia-0, wild-type; Treatment:untreated; Biological Replicate:4 of four


title: pen3_Un3

description: Three week-old mutant pen3 Arabidopsis thaliana plants, not inoculated.  Replicate 3 of four.

value: Columbia-0, wild-type; Treatment:untreated; Biological Replicate:3 of four


title: pen3_Bgh4

description: Three week-old mutant pen3 Arabidopsis thaliana plants, inoculated with Blumeria graminis hordei.  Replicate 4 of four.


title: pen3_Ec1

description: Three week-old mutant pen3 Arabidopsis thaliana plants, inoculated with Erisyphe cichoracearum.  Replicate 1 of four.

value: Columbia-0, wild-type; Treatment:inoculated with Erisyphe cichoracearum; Biological Replicate:1 of four


title: pen3_Un2

description: Three week-old mutant pen3 Arabidopsis thaliana plants, not inoculated.  Replicate 2 of four.

value: Columbia-0, wild-type; Treatment:untreated; Biological Replicate:2 of four


title: pen3_Bgh2

description: Three week-old mutant pen3 Arabidopsis thaliana plants, inoculated with Blumeria graminis hordei.  Replicate 2 of four.

value: Columbia-0, wild-type; Treatment:inoculated with Blumeria graminis hordei; Biological Replicate:2 of four


title: pen3_Ec2

description: Three week-old mutant pen3 Arabidopsis thaliana plants, inoculated with Erisyphe cichoracearum.  Replicate 2 of four.

value: Columbia-0, wild-type; Treatment:inoculated with Erisyphe cichoracearum; Biological Replicate:2 of four


title: Col_Un4

description: Three week-old wild-type Col  Arabidopsis thaliana plants, not inoculated.  Replicate 4 of four.


title: Col_Un2

description: Three week-old wild-type Col  Arabidopsis thaliana plants, not inoculated.  Replicate 2 of four.


title: pen3_Un1

description: Three week-old mutant pen3 Arabidopsis thaliana plants, not inoculated.  Replicate 1 of four.

value: Columbia-0, wild-type; Treatment:untreated; Biological Replicate:1 of four


title: Col_Ec2

description: Three week-old wild-type Col  Arabidopsis thaliana plants, inoculated with Erisyphe cichoracearum.  Replicate 2 of four.


title: Col_Bgh3

description: Three week-old wild-type Col  Arabidopsis thaliana plants, inoculated with Blumeria graminis hordei.  Replicate 3 of four.

value: Columbia-0, wild-type; Treatment:inoculated with Blumeria graminis hordei; Biological Replicate:3 of four


title: pen3_Bgh1

description: Three week-old mutant pen3 Arabidopsis thaliana plants, inoculated with Blumeria graminis hordei.  Replicate 1 of four.

value: Columbia-0, wild-type; Treatment:inoculated with Blumeria graminis hordei; Biological Replicate:1 of four


title: Col_Bgh2

description: Three week-old wild-type Col  Arabidopsis thaliana plants, inoculated with Blumeria graminis hordei.  Replicate 2 of four.


title: Col_Ec4

description: Three week-old wild-type Col  Arabidopsis thaliana plants, inoculated with Erisyphe cichoracearum.  Replicate 4 of four.

value: Columbia-0, wild-type; Treatment:inoculated with Erisyphe cichoracearum; Biological Replicate:4 of four


title: Col_Un1

description: Three week-old wild-type Col  Arabidopsis thaliana plants, not inoculated.  Replicate 1 of four.


title: Col_Ec1

description: Three week-old wild-type Col  Arabidopsis thaliana plants, inoculated with Erisyphe cichoracearum.  Replicate 1 of four.


title: Time 180 mins rep 2

description: SKGT4 oesophageal cells stimulated low pH 6.5 for 180 minutes

source_name: Low pH stimulated SKGT4 cells


title: pen3_Bgh3

description: Three week-old mutant pen3 Arabidopsis thaliana plants, inoculated with Blumeria graminis hordei.  Replicate 3 of four.


title: Col_Ec3

description: Three week-old wild-type Col  Arabidopsis thaliana plants, inoculated with Erisyphe cichoracearum.  Replicate 3 of four.


title: Col_Un3

description: Three week-old wild-type Col  Arabidopsis thaliana plants, not inoculated.  Replicate 3 of four.


title: pen3_Ec4

description: Three week-old mutant pen3 Arabidopsis thaliana plants, inoculated with Erisyphe cichoracearum.  Replicate 4 of four.


title: JMV-1-SA3-PMNsonly-1-180M-1-RML_Signal

status: Public on Sep 26 2005

city: Hamilton

first: Dan

last: Sturdevant

state: MT

address: 903 S 4th street

department: NIAID

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-PMNsonly-1-180M-1-RML_Signal

organism: Staphylococcus aureus

source_name: Sa and PMN interaction


title: JMV-1-SA3-EMRSA16-1-30M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-EMRSA16-1-30M-1-RML_Signal


title: JMV-1-SA3-PMNsonly-1-30M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-PMNsonly-1-30M-1-RML_Signal


title: JMV-1-SA3-EMRSA16-1-60M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-EMRSA16-1-60M-1-RML_Signal


title: Col_Bgh1

description: Three week-old wild-type Col  Arabidopsis thaliana plants, inoculated with Blumeria graminis hordei.  Replicate 1 of four.


title: JMV-1-SA3-PMNsonly-1-60M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-PMNsonly-1-60M-1-RML_Signal


title: JMV-1-SA3-EMRSA16-1-180M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-EMRSA16-1-180M-1-RML_Signal


title: JMV-1-SA3-Col-1-180M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-Col-1-180M-1-RML_Signal


title: JMV-1-SA3-Col-1-60M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-Col-1-60M-1-RML_Signal


title: JMV-1-SA3-Col-1-30M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-Col-1-30M-1-RML_Signal


title: JMV-1-SA3-9897?1-60M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-9897?1-60M-1-RML_Signal


title: JMV-1-SA3-EMRSA16?1-30M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-EMRSA16?1-30M-1-RML_Signal


title: JMV-1-SA3-9897-1-180M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-9897-1-180M-1-RML_Signal


title: JMV-1-SA3-9897-1-30M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-9897-1-30M-1-RML_Signal


title: JMV-1-SA3-Col?1-60M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-Col?1-60M-1-RML_Signal


title: JMV-1-SA3-Col?1-180M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-Col?1-180M-1-RML_Signal


title: JMV-1-SA3-11490-1-60M-2-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-11490-1-60M-2-RML_Signal


title: JMV-1-SA3-9897?1-30M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-9897?1-30M-1-RML_Signal


title: JMV-1-SA3-EMRSA16?1-60M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-EMRSA16?1-60M-1-RML_Signal


title: JMV-1-SA3-EMRSA16?1-180M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-EMRSA16?1-180M-1-RML_Signal


title: JMV-1-SA3-11490-1-180M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-11490-1-180M-1-RML_Signal


title: JMV-1-SA3-Col?1-30M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-Col?1-30M-1-RML_Signal


title: JMV-1-SA3-9897?1-180M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-9897?1-180M-1-RML_Signal


title: JMV-1-SA3-9897-1-60M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-9897-1-60M-1-RML_Signal


title: JMV-1-SA3-11490-1-30M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-11490-1-30M-1-RML_Signal


title: JMV-1-SA3-11490?1-30M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-11490?1-30M-1-RML_Signal


title: JMV-1-SA3-10254-1-180M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-10254-1-180M-1-RML_Signal


title: JMV-1-SA3-10254?1-60M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-10254?1-60M-1-RML_Signal


title: JMV-1-SA3-10254-1-60M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-10254-1-60M-1-RML_Signal


title: JMV-1-SA3-11490?1-180M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-11490?1-180M-1-RML_Signal


title: JMV-1-SA2-60MPMN-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-60MPMN-1-RML_Signal


title: JMV-1-SA3-10254?1-30M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-10254?1-30M-1-RML_Signal


title: JMV-1-SA3-10254?1-180M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-10254?1-180M-1-RML_Signal


title: JMV-1-SA2-60MEMRSA16-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-60MEMRSA16-1-RML_Signal


title: JMV-1-SA2-60MEMRSA16?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-60MEMRSA16?1-RML_Signal


title: JMV-1-SA2-60M9897?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-60M9897?1-RML_Signal


title: JMV-1-SA2-60M11490-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-60M11490-1-RML_Signal


title: JMV-1-SA2-60M11490?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-60M11490?1-RML_Signal


title: JMV-1-SA2-60M10254-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-60M10254-1-RML_Signal


title: JMV-1-SA2-60M10254?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-60M10254?1-RML_Signal


title: JMV-1-SA2-30MEMRSA16?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-30MEMRSA16?1-RML_Signal


title: JMV-1-SA2-30MCol-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-30MCol-1-RML_Signal


title: JMV-1-SA2-30MCol?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-30MCol?1-RML_Signal


title: JMV-1-SA2-60M9897-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-60M9897-1-RML_Signal


title: JMV-1-SA2-60MCol?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-60MCol?1-RML_Signal


title: JMV-1-SA2-30MPMN-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-30MPMN-1-RML_Signal


title: JMV-1-SA2-30M9897-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-30M9897-1-RML_Signal


title: JMV-1-SA2-30MEMRSA16-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-30MEMRSA16-1-RML_Signal


title: JMV-1-SA2-30M11490?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-30M11490?1-RML_Signal


title: JMV-1-SA2-30M10254-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-30M10254-1-RML_Signal


title: JMV-1-SA2-30M10254?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-30M10254?1-RML_Signal


title: JMV-1-SA2-30M11490-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-30M11490-1-RML_Signal


title: JMV-1-SA2-180MPMN-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-180MPMN-1-RML_Signal


title: JMV-1-SA2-180MEMRSA16?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-180MEMRSA16?1-RML_Signal


title: JMV-1-SA2-180MEMRSA16-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-180MEMRSA16-1-RML_Signal


title: JMV-1-SA3-11490?1-60M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-11490?1-60M-1-RML_Signal


title: JMV-1-SA2-180MCol-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-180MCol-1-RML_Signal


title: JMV-1-SA2-30M9897?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-30M9897?1-RML_Signal


title: JMV-1-SA2-180M9897?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-180M9897?1-RML_Signal


title: JMV-1-SA2-180M10254?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-180M10254?1-RML_Signal


title: JMV-1-SA2-180MCol?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-180MCol?1-RML_Signal


title: JMV-1-SA1-60MPMNonly-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-60MPMNonly-1-RML_Signal


title: JMV-1-SA3-10254-1-30M-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-10254-1-30M-1-RML_Signal


title: JMV-1-SA2-180M9897-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-180M9897-1-RML_Signal


title: JMV-1-SA2-180M10254-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-180M10254-1-RML_Signal


title: JMV-1-SA1-60M10254?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-60M10254?1-RML_Signal


title: JMV-1-SA1-60MEMRSA16-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-60MEMRSA16-1-RML_Signal


title: JMV-1-SA2-180M11490?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-180M11490?1-RML_Signal


title: JMV-1-SA1-60M11490?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-60M11490?1-RML_Signal


title: JMV-1-SA2-180M11490-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-180M11490-1-RML_Signal


title: JMV-1-SA1-60MEMRSA16?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-60MEMRSA16?1-RML_Signal


title: JMV-1-SA1-60M9897?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-60M9897?1-RML_Signal


title: JMV-1-SA1-60Mcol?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-60Mcol?1-RML_Signal


title: JMV-1-SA1-60M11490-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-60M11490-1-RML_Signal


title: JMV-1-SA1-60M10254-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-60M10254-1-RML_Signal


title: JMV-1-SA1-60Mcol-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-60Mcol-1-RML_Signal


title: JMV-1-SA1-60M9897-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-60M9897-1-RML_Signal


title: JMV-1-SA1-30M9897-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-30M9897-1-RML_Signal


title: JMV-1-SA1-30MEMRSA16?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-30MEMRSA16?1-RML_Signal


title: JMV-1-SA1-30MPMNonly-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-30MPMNonly-1-RML_Signal


title: JMV-1-SA1-30M11490-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-30M11490-1-RML_Signal


title: JMV-1-SA1-30MEMRSA16-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-30MEMRSA16-1-RML_Signal


title: JMV-1-SA1-30M9897?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-30M9897?1-RML_Signal


title: JMV-1-SA1-180MPMNonly-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-180MPMNonly-1-RML_Signal


title: JMV-1-SA1-30Mcol?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-30Mcol?1-RML_Signal


title: JMV-1-SA1-30M10254-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-30M10254-1-RML_Signal


title: JMV-1-SA1-30Mcol-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-30Mcol-1-RML_Signal


title: JMV-1-SA1-30M11490?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-30M11490?1-RML_Signal


title: JMV-1-SA1-30M10254?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-30M10254?1-RML_Signal


title: JMV-1-SA1-180M9897-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-180M9897-1-RML_Signal


title: JMV-1-SA1-180MEMRSA16-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-180MEMRSA16-1-RML_Signal


title: JMV-1-SA1-180MEMRSA16?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-180MEMRSA16?1-RML_Signal


title: JMV-1-SA1-180Mcol-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-180Mcol-1-RML_Signal


title: JMV-1-SA1-180Mcol?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-180Mcol?1-RML_Signal


title: JMV-1-SA1-180M10254-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-180M10254-1-RML_Signal


title: JMV-2-SA1-9897-EE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-2-SA1-9897-EE-1-RML_Signal


title: JMV-2-SA1-EMRSA16-EE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-2-SA1-EMRSA16-EE-1-RML_Signal


title: JMV-1-SA1-180M11490?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-180M11490?1-RML_Signal


title: JMV-2-SA1-11490-EE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-2-SA1-11490-EE-1-RML_Signal


title: JMV-1-SA1-180M11490-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-180M11490-1-RML_Signal


title: JMV-2-SA1-Col-EE-2-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-2-SA1-Col-EE-2-RML_Signal


title: JMV-1-SA1-180M10254?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-180M10254?1-RML_Signal


title: JMV-1-SA1-180M9897?1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-180M9897?1-RML_Signal


title: JMV-1-SA3-EMRSA-1-EE-2-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-EMRSA-1-EE-2-RML_Signal


title: JMV-1-SA3-EMRSA-3-1-ME-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-EMRSA-3-1-ME-1-RML_Signal


title: JMV-1-SA2-60MCol-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-60MCol-1-RML_Signal


title: JMV-1-SA3-Col-ES3-1_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-Col-ES3-1_Signal


title: JMV-1-SA3-EMRSA-1-LE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-EMRSA-1-LE-1-RML_Signal


title: JMV-2-SA1-10254-EE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-2-SA1-10254-EE-1-RML_Signal


title: JMV-1-SA3-Col-1-LE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-Col-1-LE-1-RML_Signal


title: JMV-1-SA3-Col-3-1-ME-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-Col-3-1-ME-1-RML_Signal


title: JMV-1-SA3-9897-1-LE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-9897-1-LE-1-RML_Signal


title: JMV-1-SA3-EMRSA-ES3-1_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-EMRSA-ES3-1_Signal


title: JMV-1-SA3-Col-1-EE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-Col-1-EE-1-RML_Signal


title: JMV-1-SA3-11490-3-1-ME-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-11490-3-1-ME-1-RML_Signal


title: JMV-1-SA3-9897-1-EE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-9897-1-EE-1-RML_Signal


title: JMV-1-SA3-10254-3-1-ME-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-10254-3-1-ME-1-RML_Signal


title: JMV-1-SA3-11490-1-EE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-11490-1-EE-1-RML_Signal


title: JMV-1-SA3-10254-1-EE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-10254-1-EE-1-RML_Signal


title: JMV-1-SA3-9897-ES3-2_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-9897-ES3-2_Signal


title: JMV-1-SA2-EMRSA-ES2-1_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-EMRSA-ES2-1_Signal


title: JMV-1-SA3-10254-ES3-1_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-10254-ES3-1_Signal


title: JMV-1-SA3-11490-ES3-1_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-11490-ES3-1_Signal


title: JMV-1-SA2-Col-LE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-Col-LE-1-RML_Signal


title: JMV-1-SA2-EMRSA16-LE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-EMRSA16-LE-1-RML_Signal


title: JMV-1-SA2-9897-ES2-1_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-9897-ES2-1_Signal


title: JMV-1-SA2-Col-EE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-Col-EE-1-RML_Signal


title: JMV-1-SA2-Col-2-1-ME-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-Col-2-1-ME-1-RML_Signal


title: JMV-1-SA2-9897-EE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-9897-EE-1-RML_Signal


title: JMV-1-SA2-9897-2-1-ME-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-9897-2-1-ME-1-RML_Signal


title: JMV-1-SA2-11490-EE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-11490-EE-1-RML_Signal


title: JMV-1-SA2-11490-LE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-11490-LE-1-RML_Signal


title: JMV-1-SA2-11490-ES2-1_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-11490-ES2-1_Signal


title: JMV-1-SA3-11490-1-LE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-11490-1-LE-1-RML_Signal


title: JMV-1-SA2-EMRSA-2-1-ME-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-EMRSA-2-1-ME-1-RML_Signal


title: JMV-1-SA2-9897-LE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-9897-LE-1-RML_Signal


title: JMV-1-SA2-11490-2-1-ME-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-11490-2-1-ME-1-RML_Signal


title: JMV-1-SA2-10254-2-1-ME-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-10254-2-1-ME-1-RML_Signal


title: JMV-1-SA1-EMRSA-ES1-1_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-EMRSA-ES1-1_Signal


title: JMV-1-SA2-10254-ES2-1_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-10254-ES2-1_Signal


title: JMV-1-SA2-10254-EE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-10254-EE-1-RML_Signal


title: JMV-1-SA3-10254-1-LE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA3-10254-1-LE-1-RML_Signal


title: JMV-1-SA1-Col-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-Col-1-RML_Signal


title: JMV-1-SA1-EMRSA-1-1-ME-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-EMRSA-1-1-ME-1-RML_Signal


title: JMV-1-SA1-Col-1-1-ME-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-Col-1-1-ME-1-RML_Signal


title: JMV-1-SA1-EMRSA16-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-EMRSA16-1-RML_Signal


title: JMV-1-SA1-Col-ES1-1_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-Col-ES1-1_Signal


title: JMV-1-SA2-Col-ES2-1_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-Col-ES2-1_Signal


title: JMV-1-SA1-9897-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-9897-1-RML_Signal


title: JMV-1-SA1-9897-ES1-1_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-9897-ES1-1_Signal


title: JMV-1-SA1-10254-ES1-1_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-10254-ES1-1_Signal


title: JMV-1-SA1-11490-1-1-ME-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-11490-1-1-ME-1-RML_Signal


title: spt10-null sample #2

status: Public on Sep 23 2005

city: Bethesda

first: David

middle: Johannes

last: Clark

address: 6 Center Drive Bldg 6A Rm 2A02

department: DDB

institute: NICHD, NIH

description:
BJ-spt10-null cells were grown in synthetic complete medium to A600 = 0.6. RNA was prepared using an RNeasy kit (Qiagen). This is #2 of three independently prepared samples.
Keywords = yeast SPT10

data_processing: Each VALUE was calculated using Affymetrix GCOS software.

label: Bioytinylated cRNAs detected by fluorescently-labelled streptavidin.

organism: Saccharomyces cerevisiae

source_name: S. cerevisiae strain BJ-spt10-null


title: JMV-1-SA1-10254-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-10254-1-RML_Signal


title: spt10-null sample #3

description:
BJ-spt10-null cells were grown in synthetic complete medium to A600 = 0.6. RNA was prepared using an RNeasy kit (Qiagen). This is #3 of three independently prepared samples.
Keywords = yeast SPT10


title: JMV-1-SA2-EMRSA16-EE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-EMRSA16-EE-1-RML_Signal


title: spt10-null sample #1

description:
BJ-spt10-null cells were grown in synthetic complete medium to A600 = 0.6. RNA was prepared using an RNeasy kit (Qiagen). This is #1 of three independently prepared samples.
Keywords = yeast SPT10


title: Wild type sample #2

description:
BJ5459 cells were grown in synthetic complete medium to A600 = 0.6. RNA was prepared using an RNeasy kit (Qiagen). This is #2 of three independently prepared samples.
Keywords = yeast SPT10

source_name: S. cerevisiae strain BJ5459


title: JMV-1-SA1-11490-ES1-1_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-11490-ES1-1_Signal


title: JMV-1-SA1-9897-1-1-ME-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-9897-1-1-ME-1-RML_Signal


title: JMV-1-SA2-10254-LE-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA2-10254-LE-1-RML_Signal


title: TaY_post-infection_day5_dup1

status: Public on Sep 22 2005

first: Tomoiku

last: Takaku

address: 6-7-1, Nishishinjuku, Shinjuku

department: First Department of internal Medicine

institute: Tokyo Medical University

description: keywork=Th2 response

hyb_protocol: Hybridization was carried out automatically using GeneTAC Hybstation (Genomic Solutions, AnnArbor, MI, US) according to the supplier’s instruction. The conditions of hybridization were 55oC for 2 hrs, 50oC for 2 hrs, and 46oC for 2 hrs, then 42oC for 12 hrs.

scan_protocol: The hybridized signals were scanned by GenePix 4000B Microarray Scanner (Axon Instruments, Union City, CA, USA) as raw data.

data_processing: The scanned data were normalized, verified, and analyzed using the Genomic Profiler software (Mitsui Industrial Knowledge Inc., Tokyo, Japan). First, the value was adjusted by subtraction of background fluorescence of an equivalent area. Analysis was done by taking the median signal of the probe value for each transcript set, and the 75% rank for the total hybridization was calculated. Microarray data obtained from three independent experiments were then verified in a single file. The normalized log data of fluorescence ratio (Cy5 to Cy3), which was quantified for each gene to reflect the relative abundance of gene in each experimental sample compared with reference sample, were deposited to GEO.

source_name: HHV-6B(OK) acutely infected TaY cells Day5

label_protocol: 20 microgram of RNA were labeled using a LabelStar Array kit (Qiagen) , according to the supplier’s instruction.

extract_protocol: Total RNA was extracted using a RNeasy Mini Kit (Qiagen, Germantown, MD, USA).The amount of RNA was measured by NanoDrop (NanoDrop Technologies, Wilmington, DE, USA), then the quality of extracted RNA was checked using a 2100 Bioanalyzer (Agilent Technologies, Wilmington, DE, USA).

treatment_protocol: A time course study was done as model of acute infection. TaY cells acutely infected by HHV-6B for 120 hrs.and were maintained  in RPMI 1640 supplemented with 20U/ml of human IL-2.

tag: An adult T cell leukemia(ATL) cell line(TaY, HTLV-1 positive, CD4 positive) infected by human herpesvirus type 6.

source_name: TaY (MOC)

treatment_protocol: TaY cells were maintained  in RPMI 1640 supplemented with 20U/ml of human IL-2.

tag: TaY (MOC)


title: TaY_post-infection_day3_dup1

description:
Keywords = human herpesvirus type 6 (HHV-6)
Keywords = Th2 response

data_processing: The scanned data was normalized, verified, and analyzed using the Genomic Profiler software (Mitsui Knowledge Industry, Co., Ltd., Tokyo, Japan). Since our pathway-focused DNA microarray contains three spots of each gene in one array and hybridization were done in duplicate, analysis was done by taking the median signal of the probe value for six transcript sets, and the 50% rank for the total hybridization was calculated. The normalized log (2) data of fluorescence ratio (Cy5 to Cy3), which was quantified for each gene to reflect the relative abundance of gene in each experimental sample compared with reference sample, were deposited to GEO.

source_name: HHV-6B(OK) acutely infected TaY cells Day3

treatment_protocol: A time course study was done as model of acute infection. TaY cells acutely infected by HHV-6B for 72 hrs.and were maintained  in RPMI 1640 supplemented with 20U/ml of human IL-2.


title: TaY_chronic infection_20U

source_name: HHV-6B(OK) chronically infected TaY cells (IL-2 20U)

treatment_protocol: TaY cells chronically infected by HHV-6B, were maintained  in RPMI 1640 supplemented with 20U/ml of human IL-2.

tag: An adult T cell leukemia(ATL) cell line(TaY, HTLV-1 positive, CD4 positive) chronically infected by human herpesvirus type 6


title: TaY_post-infection_day5_dup2

source_name: HHV-6B(OK)  infected TaY cells Day5


title: TaY_post-infection_day1_dup2

source_name: HHV-6B(OK) acutely infected TaY cells Day1

treatment_protocol: A time course study was done as model of acute infection. TaY cells acutely infected by HHV-6B for 24 hrs.and were maintained  in RPMI 1640 supplemented with 20U/ml of human IL-2.


title: TaY_chronic infection_5U

description:
To exclude the suppressive effect of IL-2 on viral replication, we also analyzed cells cultured medium with 5U/ml of IL-2.
key word=active viral infection

source_name: HHV-6B(OK) chronically infected TaY cells (IL-2 5U)

treatment_protocol: TaY cells chronically infected by HHV-6B, were maintained  in RPMI 1640 supplemented with 5U/ml of human IL-2.

tag: An adult T cell leukemia(ATL) cell line(TaY, HTLV-1 positive, CD4 positive) chronically infected by human herpesvirus type 6.


title: Wild type sample #3

description:
BJ5459 cells were grown in synthetic complete medium to A600 = 0.6. RNA was prepared using an RNeasy kit (Qiagen). This is #3 of three independently prepared samples.
Keywords = yeast SPT10

source_name: S.cerevisiae strain BJ5459


title: JMV-1-SA1-11490-1-RML_Signal

description:
To measure S. aureus gene expression during growth phase and/or S. aureus–PMN interaction.
This sample is also known as JMV-1-SA1-11490-1-RML_Signal


title: TaY_post-infection_day3_dup2

source_name: HHV-6B(OK) acute infected TaY cells Day3


title: T24 DNA fragmentation time Dye Swap

status: Public on Sep 21 2005

city: Pamplona

first: Raquel

last: Malumbres

state: Navarra

address: Avenida Pio XII 55

department: Hemato-Oncology

country: Spain

institute: University of Navarra/ Clínica Universidad de Navarra

description: Treatment of T24 cells with 2,4-dibencilaminoquinazoline during the time necessary to induce DNA fragmentation(24 hours). Dye Swap slide.

data_processing: The hybridized slides were scanned with the GMS 418 scanner (Genetic Microsystems, Woburn, MA),. After image acquisition, the scanned images were imported into “ImaGene 4.1” software (BioDiscovery) to quantify the signal intensities. Data from spots not recognized by the Imagene analysis software were excluded from further considerations (empty, poor and negative spots). We also removed data from spots identified as visually flawed (<15% in all arrays). The fluorescent median signal intensity for each spot was calculated using local median background subtraction. Data were normalized using Global mean, Dye-swap Pairs normalization and Dye Swap Fix filter 1.5 with the program ArrayNorm 1.7 (Graz, Austria)42. Log ratios above 1,7 or below -1,7 were considered as differential expression.

source_name: Treated T24 cell line

tag: T24 cell line treated with 2,4-dibencilaminoquinazoline for 24 hours

source_name: Control T24 cell line

tag: T24 cell line not treated with 2,4-dibencilaminoquinazoline (negative control)


title: HT29 DNA fragmentation time, Dye Swap

description: Treatment of T29 cells with 2,4-dibencilaminoquinazoline during the time necessary to induce DNA fragmentation(28 hours). Dye Swap slide

source_name: Treated HT29 cell line

tag: HT29 cell line treated with 2,4-dibencilaminoquinazoline for 28 hours

source_name: Control HT29 cell line

tag: HT29 cell line not treated with 2,4-dibencilaminoquinazoline (negative control)


title: HT29 DNA fragmentation time

description: Treatment of T29 cells with 2,4-dibencilaminoquinazoline during the time necessary to induce DNA fragmentation(28 hours)


title: TaY_post-infection_day1_dup1


title: T24 DNA fragmentation time

description: Treatment of T24 cells with 2,4-dibencilaminoquinazoline during the time necessary to induce DNA fragmentation(24 hours)


title: T24 caspase activation time

description: Treatment of T24 cells with 2,4-dibencilaminoquinazoline during the time necessary to induce caspase activation(20 hours).

tag: T24 cell line treated with 2,4-dibencilaminoquinazoline for 20 hours

tag: T24 cell line not treated with 2,4-dibencilaminoquinazoline (negative control).


title: T24 caspase activation time Dye Swap

description: Treatment of T24 cells with 2,4-dibencilaminoquinazoline during the time necessary to induce caspase activation(20 hours). Dye Swap slide.


title: Denervation atrophy: expression at day 7

city: Padova

first: Paolo

last: Laveder

address: via U.Bassi 58/B

department: Department of Biology

country: Italy

institute: CRIBI Biotechnology Center

description:
Frozen muscle tissue was powdered, dispersed into TRizol solution (Invitrogen, Carlsbad, CA, USA), and homogenized with an ultra-turrax-T8 blender (IKA-Werke, Staufen, Germany). Total RNA (8 µg), extracted following the manufacturer instructions, was reverse transcribed with SuperScript II (Invitrogen) and oligo-dT(21) as the primer, in the presence of either Cy3-dCTP or Cy5-dCTP (Amersham Biosciences, Uppsala, Sweden). Competitive hybridizations were carried out in a dual slide chamber (HybChamber, GeneMachines, San Carlos, CA, USA). Pellets of purified, labeled cDNAs were dissolved in hybridization buffer (Northern max, Ambion), applied on the Mouse MuscleArrays 1.0, and covered with a 22×22 mm glass coverslip. After an overnight hybridization at 42°C, slides were washed for 5 min sequentially in buffer A (1× SSC/0.1% SDS) at 65°C, buffer B (0.1× SSC/0.1% SDS) at room temperature and finally in 0.1× SSC. Digital images were generated in a GSI Lumonics LITE dual confocal laser scanner (ScanArray Microarray Analysis Software) and processed with QuantArray Analysis Software (GSI Lumonics, Ottawa, Canada). Normalized data were determined using the publicly available software SNOMAD (http://pevsnerlab.kennedykrieger.org/snomadinput.html). Normalized values (global and lowess normalization) were calculated for each spot, and converted in logarithmic scale. Final values correspond to log(2) ratio of the normalized intensities; positive numbers correspond to RNA overexpressed in denervated muscles.
Keywords = mouse
Keywords = fast-twitch muscle
Keywords = denervation
Keywords = atrophy

source_name: TA muscle from 3 mo old CD1 mouse, contralateral

source_name: TA muscle from 3 mo old CD1 mouse, 7 days after denervation


title: HT29 caspase activation time

description: Treatment of HT29 cells with 2,4-dibencilaminoquinazoline during the time necessary to induce caspase activation (24 hours)

tag: HT29 cell line treated with 2,4-dibencilaminoquinazoline for 24 hours


title: HTB26 DNA fragmentation time Dye Swap

description: Treatment of HTB26 cells with 2,4-dibencilaminoquinazoline during the time necessary to induce caspase activation(9 hours). Dye Swap slide.

source_name: Treated HTB26 cell line

tag: HTB26 cell line treated with 2,4-dibencilaminoquinazoline for 24 hours

source_name: Control HTB26 cell line

tag: HTB26 cell line not treated with 2,4-dibencilaminoquinazoline (negative control)


title: Wild type sample #1

description:
BJ5459 cells were grown in synthetic complete medium to A600 = 0.6. RNA was prepared using an RNeasy kit (Qiagen). This is #1 of three independently prepared samples.
Keywords = yeast SPT10

source_name: S. cerevisiae strain BJ5459


title: Denervation atrophy: expression at day 14

source_name: TA muscle from 3 mo old CD1 mouse, 14 days after denervation


title: HTB26 caspase activation time

description: Treatment of HTB26 cells with 2,4-dibencilaminoquinazoline during the time necessary to induce caspase activation(9 hours)

tag: HTB26 cell line treated with 2,4-dibencilaminoquinazoline for 9 hours


title: Denervation atrophy: expression at day 7 (reverse labeling)


title: Denervation atrophy: expression at time 0 (reverse labeling)

source_name: TA muscle from 3 mo old CD1 mouse, denervated


title: Denervation atrophy: expression at day 3 (reverse labeling)

source_name: TA muscle from 3 mo old CD1 mouse, 3 days after denervation


title: Denervation atrophy: expression at day 1 (reverse labeling)

source_name: TA muscle from 3 mo old CD1 mouse, 1 day after denervation


title: Denervation atrophy: expression at time 0


title: male patient 058 - Cy3

status: Public on Sep 16 2005

type: genomic

city: Nijmegen

first: Joris

middle: Andre

last: Veltman

address: Geert Grooteplein 10

department: Human Genetics

country: Netherlands

institute: Radboud University Nijmegen Medical Centre

description: Analysis genomic DNA male patient 058

hyb_protocol: Test and reference samples were mixed with 120 µg human Cot-1 DNA, co-precipitated and resuspended in 120 µl of a hybridization solution containing 50% formamide, 10% dextran sulfate, 2X SCC, 4% SDS and 10 µg/µl yeast tRNA. Overnight hybridization and post-hybridization washing procedures were performed using a GeneTac Hybridization Station

scan_protocol: Fluorescent array images were collected for both Cy3 and Cy5 with a GenePix 4200AL fluorescent scanner and image intensity data were extracted and analyzed with GenePix Pro 5.0 analysis software.

data_processing: The log2 transformed test over reference ratio for each clone was normalized by subtracting its local mean log2 test over reference ratio obtained by a weighted median filter (Yin and Yang 1996). This filter averages the log ratios of autosomal clones weighted by a Gaussian with its mean at the spot to be normalized and a standard deviation of one physical millimetre on the array.

molecule: genomic DNA

source_name: Genomic DNA isolated from blood male patient 058

label_protocol: Five hundred nanogram of genomic DNA was labelled by random priming with Cy3-dUTP

tag: Genomic DNA isolated from blood

source_name: A reference pool of genomic DNA isolated from 10 female blood donors

label_protocol: Five hundred nanogram of genomic DNA was labelled by random priming with Cy5-dUTP


title: female patient 057 - Cy3

description: Analysis genomic DNA female patient 057

source_name: Genomic DNA isolated from blood female patient 057

source_name: A reference pool of genomic DNA isolated from 10 male blood donors


title: HT29 caspase activation time, Dye Swap

description: Treatment of T29 cells with 2,4-dibencilaminoquinazoline during the time necessary to induce caspase activation(24 hours). Dye Swap slide.


title: male patient 031 - Cy3

description: Analysis genomic DNA male patient 031

source_name: Genomic DNA isolated from blood male patient 031


title: Denervation atrophy: expression at day 3


title: male patient 046 - Cy3

description: Analysis genomic DNA male patient 046

source_name: Genomic DNA isolated from blood male patient 046


title: female patient 088 - Cy3

description: Analysis genomic DNA female patient 088

source_name: Genomic DNA isolated from blood female patient 088


title: HTB26 caspase activation time Dye Swap


title: female patient 073 - Cy3

description: Analysis genomic DNA female patient 073

source_name: Genomic DNA isolated from blood female patient 073


title: female patient 076 - Cy3

description: Analysis genomic DNA female patient 076

source_name: Genomic DNA isolated from blood female patient 076


title: female patient 052 - Cy3

description: Analysis genomic DNA female patient 052

source_name: Genomic DNA isolated from blood female patient 052


title: male patient 229 - Cy5

description: Analysis genomic DNA male patient 229

source_name: Genomic DNA isolated from blood male patient 229


title: male patient 008 - Cy3

description: Analysis genomic DNA male patient 008

source_name: Genomic DNA isolated from blood male patient 008


title: male patient 023 - Cy3

description: Analysis genomic DNA male patient 023

source_name: Genomic DNA isolated from blood male patient 023


title: Denervation atrophy: expression at day 1

source_name: TA muscle from 3 mo old CD1 mouse, contralateral


title: male patient 081 - Cy5

description: Analysis genomic DNA male patient 081

source_name: Genomic DNA isolated from blood male patient 081


title: HTB26 DNA fragmentation time

description: Treatment of HTB26 cells with 2,4-dibencilaminoquinazoline during the time necessary to induce DNA fragmentation (24 hours)

source_name: Treated HTB26 cell line

source_name: Control HTB26 cell line


title: male patient 051 - Cy3

description: Analysis genomic DNA male patient 051

source_name: Genomic DNA isolated from blood male patient 051


title: female patient 240 - Cy3

description: Analysis genomic DNA female patient 240

source_name: Genomic DNA isolated from blood female patient 240


title: female patient 055 - Cy3

description: Analysis genomic DNA female patient 055

source_name: Genomic DNA isolated from blood female patient 055


title: Denervation atrophy: expression at day 14 (reverse labeling)

source_name: TA muscle from 3 mo old CD1 mouse, 14 days after denervation


title: female patient 139 - Cy3

description: Analysis genomic DNA female patient 139

source_name: Genomic DNA isolated from blood female patient 139

source_name: A reference pool of genomic DNA isolated from 10 male blood donors


title: female patient 012 - Cy5

description: Analysis genomic DNA female patient 012

source_name: Genomic DNA isolated from blood female patient 012


title: male patient 034 - Cy3

description: Analysis genomic DNA male patient 034

source_name: Genomic DNA isolated from blood male patient 034

source_name: A reference pool of genomic DNA isolated from 10 female blood donors


title: male patient 078 - Cy5

description: Analysis genomic DNA male patient 078

source_name: Genomic DNA isolated from blood male patient 078


title: male patient 080 - Cy5

description: Analysis genomic DNA male patient 080

source_name: Genomic DNA isolated from blood male patient 080


title: male patient 078 - Cy3

description: Analysis genomic DNA male patient 078


title: male patient 229 - Cy3

description: Analysis genomic DNA male patient 229

source_name: Genomic DNA isolated from blood male patient 229


title: female patient 012 - Cy3

description: Analysis genomic DNA female patient 012


title: mother patient 186 - Cy3

description: Analysis genomic DNA mother patient 186

source_name: Genomic DNA isolated from blood mother patient 186


title: female patient 300 - Cy3

description: Analysis genomic DNA female patient 300

source_name: Genomic DNA isolated from blood female patient 300


title: father patient 186 - Cy3

description: Analysis genomic DNA father patient 186

source_name: Genomic DNA isolated from blood father patient 186


title: male patient 096 - Cy3

description: Analysis genomic DNA male patient 096

source_name: Genomic DNA isolated from blood male patient 096


title: father patient 319 - Cy3

description: Analysis genomic DNA father patient 319

source_name: Genomic DNA isolated from blood father patient 319


title: mother patient 034 - Cy3

description: Analysis genomic DNA mother patient 034

source_name: Genomic DNA isolated from blood mother patient 034


title: mother patient 350 - Cy3

description: Analysis genomic DNA mother patient 350

source_name: Genomic DNA isolated from blood mother patient 350


title: mother patient 240 - Cy3

description: Analysis genomic DNA mother patient 240

source_name: Genomic DNA isolated from blood mother patient 240


title: male patient 342 - Cy5

description: Analysis genomic DNA male patient 342

source_name: Genomic DNA isolated from blood male patient 342


title: mother patient 204 - Cy3

description: Analysis genomic DNA mother patient 204

source_name: Genomic DNA isolated from blood mother patient 204


title: male patient 186 - Cy3

description: Analysis genomic DNA male patient 186

source_name: Genomic DNA isolated from blood male patient 186


title: father patient 342 - Cy3

description: Analysis genomic DNA father patient 342

source_name: Genomic DNA isolated from blood father patient 342


title: father patient 240 - Cy3

description: Analysis genomic DNA father patient 240

source_name: Genomic DNA isolated from blood father patient 240

source_name: A reference pool of genomic DNA isolated from 10 male blood donors


title: mother patient 342 - Cy3

description: Analysis genomic DNA mother patient 342

source_name: Genomic DNA isolated from blood mother patient 342

source_name: A reference pool of genomic DNA isolated from 10 female blood donors


title: mother patient 057 - Cy3

description: Analysis genomic DNA mother patient 057

source_name: Genomic DNA isolated from blood mother patient 057


title: mother patient 171 - Cy3

description: Analysis genomic DNA mother patient 171

source_name: Genomic DNA isolated from blood mother patient 171


title: father patient 301 - Cy3

description: Analysis genomic DNA father patient 301

source_name: Genomic DNA isolated from blood father patient 301


title: father patient 057 - Cy3

description: Analysis genomic DNA father patient 057

source_name: Genomic DNA isolated from blood father patient 057


title: father patient 258 - Cy3

description: Analysis genomic DNA father patient 258

source_name: Genomic DNA isolated from blood father patient 258


title: mother patient 070 - Cy3

description: Analysis genomic DNA mother patient 070

source_name: Genomic DNA isolated from blood mother patient 070


title: father patient 042 - Cy3

description: Analysis genomic DNA father patient 042

source_name: Genomic DNA isolated from blood father patient 042


title: father patient 171 - Cy3

description: Analysis genomic DNA father patient 171

source_name: Genomic DNA isolated from blood father patient 171


title: father patient 350 - Cy3

description: Analysis genomic DNA father patient 350

source_name: Genomic DNA isolated from blood father patient 350


title: mother patient 301 - Cy3

description: Analysis genomic DNA mother patient 301

source_name: Genomic DNA isolated from blood mother patient 301


title: mother patient 258 - Cy3

description: Analysis genomic DNA mother patient 258

source_name: Genomic DNA isolated from blood mother patient 258


title: father patient 070 - Cy3

description: Analysis genomic DNA father patient 070

source_name: Genomic DNA isolated from blood father patient 070


title: mother patient 042 - Cy3

description: Analysis genomic DNA mother patient 042

source_name: Genomic DNA isolated from blood mother patient 042


title: father patient 039 - Cy3

description: Analysis genomic DNA father patient 039

source_name: Genomic DNA isolated from blood father patient 039


title: mother patient 319 - Cy3

description: Analysis genomic DNA mother patient 319

source_name: Genomic DNA isolated from blood mother patient 319


title: mother patient 039 - Cy3

description: Analysis genomic DNA mother patient 039

source_name: Genomic DNA isolated from blood mother patient 039


title: father patient 027 - Cy3

description: Analysis genomic DNA father patient 027

source_name: Genomic DNA isolated from blood father patient 027

source_name: A reference pool of genomic DNA isolated from 10 female blood donors


title: father patient 046 - Cy3

description: Analysis genomic DNA father patient 046

source_name: Genomic DNA isolated from blood father patient 046


title: male patient 404 - Cy5

description: Analysis genomic DNA male patient 404

source_name: Genomic DNA isolated from blood male patient 404


title: male patient 307 - Cy5

description: Analysis genomic DNA male patient 307

source_name: Genomic DNA isolated from blood male patient 307


title: male patient 190 - Cy3

description: Analysis genomic DNA male patient 190

source_name: Genomic DNA isolated from blood male patient 190


title: female patient 052 - Cy5

description: Analysis genomic DNA female patient 052

source_name: A reference pool of genomic DNA isolated from 10 male blood donors

source_name: Genomic DNA isolated from blood female patient 052


title: female patient 306 - Cy5

description: Analysis genomic DNA female patient 306

source_name: Genomic DNA isolated from blood female patient 306


title: father patient 498 - Cy3

description: Analysis genomic DNA father patient 498

source_name: Genomic DNA isolated from blood father patient 498


title: male patient 014 - Cy5

description: Analysis genomic DNA male patient 014

source_name: Genomic DNA isolated from blood male patient 014


title: mother patient 498 - Cy3

description: Analysis genomic DNA mother patient 498

source_name: Genomic DNA isolated from blood mother patient 498


title: male patient 190 - Cy5

description: Analysis genomic DNA male patient 190


title: female patient 306 - Cy3

description: Analysis genomic DNA female patient 306


title: male patient 307 - Cy3

description: Analysis genomic DNA male patient 307


title: male patient 350 - Cy3

description: Analysis genomic DNA male patient 350

source_name: Genomic DNA isolated from blood male patient 350


title: male patient 138 - Cy5

description: Analysis genomic DNA male patient 138

source_name: Genomic DNA isolated from blood male patient 138


title: female patient 176 - Cy5

description: Analysis genomic DNA female patient 176

source_name: Genomic DNA isolated from blood female patient 176


title: male patient 070 - Cy5

description: Analysis genomic DNA male patient 070

source_name: Genomic DNA isolated from blood male patient 070


title: male patient 350 - Cy5

description: Analysis genomic DNA male patient 350


title: male patient 142 - Cy5

description: Analysis genomic DNA male patient 142

source_name: Genomic DNA isolated from blood male patient 142


title: male patient 158 - Cy5

description: Analysis genomic DNA male patient 158

source_name: Genomic DNA isolated from blood male patient 158


title: male patient 404 - Cy3

description: Analysis genomic DNA male patient 404

source_name: A reference pool of genomic DNA isolated from 10 female blood donors


title: female patient 226 - Cy3

description: Analysis genomic DNA female patient 226

source_name: Genomic DNA isolated from blood female patient 226


title: male patient 186 - Cy5

description: Analysis genomic DNA male patient 186

source_name: Genomic DNA isolated from blood male patient 186


title: male patient 141 - Cy5

description: Analysis genomic DNA male patient 141

source_name: Genomic DNA isolated from blood male patient 141


title: mother patient 046 - Cy3

description: Analysis genomic DNA mother patient 046

source_name: Genomic DNA isolated from blood mother patient 046


title: male patient 017 - Cy3

description: Analysis genomic DNA male patient 017

source_name: Genomic DNA isolated from blood male patient 017


title: female patient 189 - Cy3

description: Analysis genomic DNA female patient 189

source_name: Genomic DNA isolated from blood female patient 189

source_name: A reference pool of genomic DNA isolated from 10 male blood donors


title: male patient 198 - Cy3

description: Analysis genomic DNA male patient 198

source_name: Genomic DNA isolated from blood male patient 198


title: male patient 171 - Cy3

description: Analysis genomic DNA male patient 171

source_name: Genomic DNA isolated from blood male patient 171


title: male patient 185 - Cy3

description: Analysis genomic DNA male patient 185

source_name: Genomic DNA isolated from blood male patient 185


title: male patient 194 - Cy5

description: Analysis genomic DNA male patient 194

source_name: Genomic DNA isolated from blood male patient 194


title: male patient 028 - Cy5

description: Analysis genomic DNA male patient 028

source_name: Genomic DNA isolated from blood male patient 028


title: male patient 192 - Cy5

description: Analysis genomic DNA male patient 192

source_name: Genomic DNA isolated from blood male patient 192


title: female patient 159 - Cy5

description: Analysis genomic DNA female patient 159

source_name: Genomic DNA isolated from blood female patient 159


title: female patient 169 - Cy3

description: Analysis genomic DNA female patient 169

source_name: Genomic DNA isolated from blood female patient 169


title: male patient 185 - Cy5

description: Analysis genomic DNA male patient 185


title: female patient 189 - Cy5

description: Analysis genomic DNA female patient 189


title: male patient 134 - Cy5

description: Analysis genomic DNA male patient 134

source_name: Genomic DNA isolated from blood male patient 134


title: female patient 176 - Cy3

description: Analysis genomic DNA female patient 176

source_name: Genomic DNA isolated from blood female patient 176


title: female patient 063 - Cy5

description: Analysis genomic DNA female patient 063

source_name: Genomic DNA isolated from blood female patient 063


title: female patient 123 - Cy3

description: Analysis genomic DNA female patient 123

source_name: Genomic DNA isolated from blood female patient 123


title: female patient 054 - Cy3

description: Analysis genomic DNA female patient 054

source_name: Genomic DNA isolated from blood female patient 054


title: female patient 169 - Cy5

description: Analysis genomic DNA female patient 169


title: female patient 117 - Cy5

description: Analysis genomic DNA female patient 117

source_name: Genomic DNA isolated from blood female patient 117


title: male patient 198 - Cy5

description: Analysis genomic DNA male patient 198

source_name: A reference pool of genomic DNA isolated from 10 female blood donors


title: male patient 148 - Cy5

description: Analysis genomic DNA male patient 148

source_name: Genomic DNA isolated from blood male patient 148


title: female patient 057 - Cy5

description: Analysis genomic DNA female patient 057

source_name: A reference pool of genomic DNA isolated from 10 male blood donors

source_name: Genomic DNA isolated from blood female patient 057


title: female patient 136 - Cy5

description: Analysis genomic DNA female patient 136

source_name: Genomic DNA isolated from blood female patient 136


title: female patient 005 - Cy5

description: Analysis genomic DNA female patient 005

source_name: Genomic DNA isolated from blood female patient 005


title: female patient 117 - Cy3

description: Analysis genomic DNA female patient 117


title: male patient 080 - Cy3

description: Analysis genomic DNA male patient 080

source_name: Genomic DNA isolated from blood male patient 080


title: male patient 138 - Cy3

description: Analysis genomic DNA male patient 138

source_name: Genomic DNA isolated from blood male patient 138


title: male patient 158 - Cy3

description: Analysis genomic DNA male patient 158

source_name: Genomic DNA isolated from blood male patient 158


title: female patient 178 - Cy3

description: Analysis genomic DNA female patient 178

source_name: Genomic DNA isolated from blood female patient 178


title: male patient 128 - Cy3

description: Analysis genomic DNA male patient 128

source_name: Genomic DNA isolated from blood male patient 128


title: female patient 159 - Cy3

description: Analysis genomic DNA female patient 159

source_name: Genomic DNA isolated from blood female patient 159


title: male patient 113 - Cy5

description: Analysis genomic DNA male patient 113

source_name: Genomic DNA isolated from blood male patient 113


title: female patient 123 - Cy5

description: Analysis genomic DNA female patient 123


title: male patient 204 - Cy5

description: Analysis genomic DNA male patient 204

source_name: Genomic DNA isolated from blood male patient 204


title: male patient 179 - Cy3

description: Analysis genomic DNA male patient 179

source_name: Genomic DNA isolated from blood male patient 179


title: female patient 111 - Cy5

description: Analysis genomic DNA female patient 111

source_name: Genomic DNA isolated from blood female patient 111


title: male patient 148 - Cy3

description: Analysis genomic DNA male patient 148


title: male patient 142 - Cy3

description: Analysis genomic DNA male patient 142

source_name: Genomic DNA isolated from blood male patient 142


title: female patient 140 - Cy3

description: Analysis genomic DNA female patient 140

source_name: Genomic DNA isolated from blood female patient 140


title: male patient 134 - Cy3

description: Analysis genomic DNA male patient 134

source_name: Genomic DNA isolated from blood male patient 134

source_name: A reference pool of genomic DNA isolated from 10 female blood donors


title: father patient 49 - Cy3

description: Analysis genomic DNA father patient 49

source_name: Genomic DNA isolated from blood father patient 49


title: male patient 192 - Cy3

description: Analysis genomic DNA male patient 192

source_name: Genomic DNA isolated from blood male patient 192


title: male patient 141 - Cy3

description: Analysis genomic DNA male patient 141

source_name: Genomic DNA isolated from blood male patient 141


title: male patient 094 - Cy3

description: Analysis genomic DNA male patient 094

source_name: Genomic DNA isolated from blood male patient 094


title: female patient 136 - Cy3

description: Analysis genomic DNA female patient 136

source_name: Genomic DNA isolated from blood female patient 136

source_name: A reference pool of genomic DNA isolated from 10 male blood donors


title: male patient 193 - Cy3

description: Analysis genomic DNA male patient 193

source_name: Genomic DNA isolated from blood male patient 193


title: male patient 238 - Cy3

description: Analysis genomic DNA male patient 238

source_name: Genomic DNA isolated from blood male patient 238


title: male patient 193 - Cy5

description: Analysis genomic DNA male patient 193


title: male patient 205 - Cy3

description: Analysis genomic DNA male patient 205

source_name: Genomic DNA isolated from blood male patient 205


title: male patient 208 - Cy3

description: Analysis genomic DNA male patient 208

source_name: Genomic DNA isolated from blood male patient 208


title: male patient 205 - Cy5

description: Analysis genomic DNA male patient 205


title: male patient 242 - Cy3

description: Analysis genomic DNA male patient 242

source_name: Genomic DNA isolated from blood male patient 242


title: mother patient 49 - Cy3

description: Analysis genomic DNA mother patient 49

source_name: Genomic DNA isolated from blood mother patient 49


title: male patient 204 - Cy3

description: Analysis genomic DNA male patient 204

source_name: Genomic DNA isolated from blood male patient 204


title: male patient 179 - Cy5

description: Analysis genomic DNA male patient 179

source_name: Genomic DNA isolated from blood male patient 179


title: female patient 249 - Cy5

description: Analysis genomic DNA female patient 249

source_name: Genomic DNA isolated from blood female patient 249


title: male patient 279 - Cy3

description: Analysis genomic DNA male patient 279

source_name: Genomic DNA isolated from blood male patient 279


title: male patient 238 - Cy5

description: Analysis genomic DNA male patient 238

source_name: A reference pool of genomic DNA isolated from 10 female blood donors


title: mother patient 300 - Cy3

description: Analysis genomic DNA mother patient 300

source_name: Genomic DNA isolated from blood mother patient 300


title: female patient 261 - Cy5

description: Analysis genomic DNA female patient 261

source_name: Genomic DNA isolated from blood female patient 261


title: male patient 207 - Cy3

description: Analysis genomic DNA male patient 207

source_name: Genomic DNA isolated from blood male patient 207


title: female patient 178 - Cy5

description: Analysis genomic DNA female patient 178

source_name: Genomic DNA isolated from blood female patient 178


title: father patient 300 - Cy3

description: Analysis genomic DNA father patient 300

source_name: Genomic DNA isolated from blood father patient 300


title: female patient 249 - Cy3

description: Analysis genomic DNA female patient 249

source_name: A reference pool of genomic DNA isolated from 10 male blood donors


title: female patient 226 - Cy5

description: Analysis genomic DNA female patient 226

source_name: Genomic DNA isolated from blood female patient 226


title: male patient 283 - Cy5

description: Analysis genomic DNA male patient 283

source_name: Genomic DNA isolated from blood male patient 283


title: male patient 207 - Cy5

description: Analysis genomic DNA male patient 207


title: female patient 261 - Cy3

description: Analysis genomic DNA female patient 261


title: father patient 008 - Cy3

description: Analysis genomic DNA father patient 008

source_name: Genomic DNA isolated from blood father patient 008


title: male patient 171 - Cy5

description: Analysis genomic DNA male patient 171

source_name: Genomic DNA isolated from blood male patient 171


title: male patient 242 - Cy5

description: Analysis genomic DNA male patient 242

source_name: Genomic DNA isolated from blood male patient 242


title: male patient 282 - Cy5

description: Analysis genomic DNA male patient 282

source_name: Genomic DNA isolated from blood male patient 282


title: mother patient 148 - Cy3

description: Analysis genomic DNA mother patient 148

source_name: Genomic DNA isolated from blood mother patient 148


title: male patient 128 - Cy5

description: Analysis genomic DNA male patient 128

source_name: Genomic DNA isolated from blood male patient 128


title: male patient 208 - Cy5

description: Analysis genomic DNA male patient 208

source_name: Genomic DNA isolated from blood male patient 208


title: male patient 258 - Cy5

description: Analysis genomic DNA male patient 258

source_name: Genomic DNA isolated from blood male patient 258


title: mother patient 008 - Cy3

description: Analysis genomic DNA mother patient 008

source_name: Genomic DNA isolated from blood mother patient 008

source_name: A reference pool of genomic DNA isolated from 10 female blood donors


title: female patient 301 - Cy5

description: Analysis genomic DNA female patient 301

source_name: Genomic DNA isolated from blood female patient 301


title: male patient 279 - Cy5

description: Analysis genomic DNA male patient 279

source_name: Genomic DNA isolated from blood male patient 279


title: male patient 295 - Cy5

description: Analysis genomic DNA male patient 295

source_name: Genomic DNA isolated from blood male patient 295


title: mother patient 096 - Cy3

description: Analysis genomic DNA mother patient 096

source_name: Genomic DNA isolated from blood mother patient 096


title: male patient 258 - Cy3

description: Analysis genomic DNA male patient 258


title: male patient 298 - Cy3

description: Analysis genomic DNA male patient 298

source_name: Genomic DNA isolated from blood male patient 298


title: female patient 140 - Cy5

description: Analysis genomic DNA female patient 140

source_name: A reference pool of genomic DNA isolated from 10 male blood donors

source_name: Genomic DNA isolated from blood female patient 140


title: female patient 001 - Cy3

description: Analysis genomic DNA female patient 001

source_name: Genomic DNA isolated from blood female patient 001


title: male patient 028 - Cy3

description: Analysis genomic DNA male patient 028

source_name: Genomic DNA isolated from blood male patient 028


title: female patient 301 - Cy3

description: Analysis genomic DNA female patient 301


title: female patient 001 - Cy5

description: Analysis genomic DNA female patient 001


title: male patient 342 - Cy3

description: Analysis genomic DNA male patient 342

source_name: Genomic DNA isolated from blood male patient 342


title: father patient 096 - Cy3

description: Analysis genomic DNA father patient 096

source_name: Genomic DNA isolated from blood father patient 096


title: male patient 295 - Cy3

description: Analysis genomic DNA male patient 295


title: male patient 298 - Cy5

description: Analysis genomic DNA male patient 298


title: male patient 283 - Cy3

description: Analysis genomic DNA male patient 283

source_name: Genomic DNA isolated from blood male patient 283


title: male patient 282 - Cy3

description: Analysis genomic DNA male patient 282

source_name: Genomic DNA isolated from blood male patient 282


title: female patient 498 - Cy3

description: Analysis genomic DNA female patient 498

source_name: Genomic DNA isolated from blood female patient 498


title: female patient 038 - Cy3

description: Analysis genomic DNA female patient 038

source_name: Genomic DNA isolated from blood female patient 038


title: female patient 002 - Cy3

description: Analysis genomic DNA female patient 002

source_name: Genomic DNA isolated from blood female patient 002


title: female patient 042 - Cy5

description: Analysis genomic DNA female patient 042

source_name: Genomic DNA isolated from blood female patient 042


title: female patient 042 - Cy3

description: Analysis genomic DNA female patient 042


title: male patient 122 - Cy3

description: Analysis genomic DNA male patient 122

source_name: Genomic DNA isolated from blood male patient 122

source_name: A reference pool of genomic DNA isolated from 10 female blood donors


title: female patient 139 - Cy5

description: Analysis genomic DNA female patient 139

source_name: Genomic DNA isolated from blood female patient 139


title: female patient 498 - Cy5

description: Analysis genomic DNA female patient 498


title: male patient 027 - Cy3

description: Analysis genomic DNA male patient 027

source_name: Genomic DNA isolated from blood male patient 027


title: male patient 250 - Cy3

description: Analysis genomic DNA male patient 250

source_name: Genomic DNA isolated from blood male patient 250


title: male patient 014 - Cy3

description: Analysis genomic DNA male patient 014

source_name: Genomic DNA isolated from blood male patient 014


title: male patient 049 - Cy3

description: Analysis genomic DNA male patient 049

source_name: Genomic DNA isolated from blood male patient 049


title: male patient 049 - Cy5

description: Analysis genomic DNA male patient 049